Remarkable response to Osimertinib plus Gumarontinib for EGFR mutation and concomitant MET exon 14 skipping in a patient with lung adenocarcinoma: A case report. - Jing, Xuquan; Li, Li; Lu, Shuangqing; Zhai, Xiaoyang; Zhu, Hui (Oncology Letters, 2026)